Amdocs Stock Performance
| DOX Stock | USD 85.11 0.18 0.21% |
The firm shows a Beta (market volatility) of 1.12, which signifies a somewhat significant risk relative to the market. Amdocs returns are very sensitive to returns on the market. As the market goes up or down, Amdocs is expected to follow. Amdocs has an expected return of -0.12%. Please make sure to confirm Amdocs treynor ratio, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Amdocs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Amdocs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return 0.13 | Five Day Return (2.69) | Year To Date Return (3.37) | Ten Year Return 83.87 | All Time Return 506.64 |
Forward Dividend Yield 0.0225 | Payout Ratio 0.2963 | Forward Dividend Rate 1.92 | Dividend Date 2024-04-26 | Ex Dividend Date 2024-03-27 |
| Amdocs dividend paid on 26th of January 2024 | 01/26/2024 |
1 | Amdocs announces multi-year agreement with Australia-based TPG Telecom | 02/06/2024 |
2 | Dell Technologies Telecom Solutions Accelerate Network Cloud Transformation | 02/21/2024 |
3 | Customer Relationship Management Market To Reach USD 164.8 Billion By 2032 Report By DataHorizzon Research | 03/14/2024 |
4 | Want Better Returns Dont Ignore These 2 Computer and Technology Stocks Set to Beat Earnings | 03/19/2024 |
5 | Amdocs Reveals Insightful Generative AI Research | 03/21/2024 |
6 | VIAVI Demonstrates Leadership in RAN Intelligence Test and Training at 2024 RIC Forum | 03/28/2024 |
7 | Amdocs shareholders have earned a 13 percent CAGR over the last five years | 04/01/2024 |
8 | Versapay Appoints Gaby Kozakov as Chief Technology Officer | 04/02/2024 |
9 | DOX vs. DT Which Stock Is the Better Value Option | 04/09/2024 |
10 | DekaBank Deutsche Girozentrale Increases Holdings in Amdocs Limited - MarketBeat | 04/11/2024 |
11 | Xperi Mails Definitive Proxy Statement and Issues Letter to Stockholders Highlighting the Companys Transformation, Strategy and Business Progress | 04/17/2024 |
| Begin Period Cash Flow | 573.4 M |
Amdocs |
Amdocs Relative Risk vs. Return Landscape
If you would invest 9,217 in Amdocs on January 19, 2024 and sell it today you would lose (706.00) from holding Amdocs or give up 7.66% of portfolio value over 90 days. Amdocs is generating negative expected returns assuming volatility of 1.0102% on return distribution over 90 days investment horizon. In other words, 8% of stocks are less volatile than Amdocs, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Amdocs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amdocs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amdocs, and traders can use it to determine the average amount a Amdocs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1202
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DOX |
Estimated Market Risk
| 1.01 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amdocs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amdocs by adding Amdocs to a well-diversified portfolio.
Amdocs Fundamentals Growth
Amdocs Stock prices reflect investors' perceptions of the future prospects and financial health of Amdocs, and Amdocs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amdocs Stock performance.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.071 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 10.15 B | |||
| Shares Outstanding | 116.5 M | |||
| Price To Earning | 19.03 X | |||
| Price To Book | 2.81 X | |||
| Price To Sales | 2.02 X | |||
| Revenue | 4.89 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 920.59 M | |||
| Net Income | 542.96 M | |||
| Cash And Equivalents | 817.98 M | |||
| Cash Per Share | 6.74 X | |||
| Total Debt | 807.31 M | |||
| Debt To Equity | 0.23 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 30.55 X | |||
| Cash Flow From Operations | 822.63 M | |||
| Earnings Per Share | 4.68 X | |||
| Market Capitalization | 9.88 B | |||
| Total Asset | 6.43 B | |||
| Retained Earnings | 6.55 B | |||
| Working Capital | 558.25 M | |||
| Current Asset | 2.1 B | |||
| Current Liabilities | 1.37 B | |||
About Amdocs Performance
To evaluate Amdocs Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Amdocs generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Amdocs Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Amdocs market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Amdocs's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00000012 | 0.00 | |
| Return On Tangible Assets | 0.14 | 0.10 | |
| Return On Capital Employed | 0.15 | 0.14 | |
| Return On Assets | 0.08 | 0.06 | |
| Return On Equity | 0.14 | 0.07 |
Things to note about Amdocs performance evaluation
Checking the ongoing alerts about Amdocs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amdocs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Amdocs generated a negative expected return over the last 90 days | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Xperi Mails Definitive Proxy Statement and Issues Letter to Stockholders Highlighting the Companys Transformation, Strategy and Business Progress |
- Analyzing Amdocs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Amdocs' stock is overvalued or undervalued compared to its peers.
- Examining Amdocs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Amdocs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Amdocs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Amdocs' stock. These opinions can provide insight into Amdocs' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.